Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.

Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection. Abstract Text:

Curtis L Cooper,Ed Mills,Curtis L Cooper,Ed Mills,

Hepatitis C virus (HCV) and hepatitis B virus (HBV) co-infection may differentially influence HIV treatment duration and outcome. This was assessed at The Ottawa Hospital Immunodeficiency Clinic in first-time highly active antiretroviral therapy (HAART) recipients visited between January 2000 and December 2004. Of 968 patients, 526/700 (75%) HIV, 173/230 (75%) HIV-HCV and 30/38 (79%) HIV-HBV-infected patients initiated HAART. Co-infected patients stopped treatment sooner (HBV - 10 months, HCV - 9 months) than HIV mono-infected (17 months) (P<0.001). Injection drug history predicted shorter treatment duration (odds ratio [OR]1.59, P<0.001). Use of non-nucleoside-reverse-transcriptase-inhibitor-containing HAART (OR 0.76, P<0.01) and low-dose ritonavir (<400 mg twice daily)-based HAART (OR 0.83, P = 0.06) predicted longer treatment duration. HCV co-infection did not predict duration of therapy (OR 1.19, P=0.19) once controlled for by these three variables. Poor adherence was a major explanation for eventual treatment interruption in those with HIV-HCV (22% versus 5% in HIV alone; P<0.001) as was substance abuse (7% versus < 1% in HIV; P<0.001). Metabolic complications resulted in HAART interruption in HIV mono-infection (8%) but not with HBV or HCV co-infection (both <1%; P<0.001). Antiretroviral selection is critical to the longevity of initially prescribed regimens, irrespective of viral hepatitis co-infection. Attention to this and strategies targeting substance abuse and adherence in HIV-HCV are predicted to increase the duration of HAART.

Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection. Publishing Authors By Initials

CL Cooper,E Mills,CL Cooper,E Mills,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: International journal of STD & AIDS

VOLUME: 18

Page Numbers: 546-50

Journal Abbreviation:

ISSN: 0956-4624

DAY: 9

MONTH: Aug

YEAR: 2007

Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9007917

Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.

AFFILIATION: Department of Medicine, Division of Infectious Diseases, The Ottawa Hospital, University of Ottawa, G12-501 Smyth Road, Ottawa, Ontario, Canada. ccooper@ottawahospital.on.ca

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J STD AIDS

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection Related Publications

• A cost analysis of Kilifi and Malindi public hospitals in Kenya.
• Are children with imaginary playmates and children said to remember previous lives cross-culturally comparable categories?
• Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
• Association of blood pressure and fitness with levels of atherosclerotic risk markers pre-exercise and post-exercise.
• CHD5 is a tumor suppressor at human 1p36.
• Comparative genomics of the lactic acid bacteria.
• Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
• Conflict and health: a paradigm shift in global health and human rights.
• Critical Time Intervention: an empirically supported model for preventing homelessness in high risk groups.
• Critical limb ischemia.
• Design and synthesis of a theophylline bonded-phase column for HPLC - application to separation of aromatic carboxylic acids.
• Determining the cause of hearing loss: differential diagnosis using a comparison of audiometric and otoacoustic emission responses.
• Effect of withholding feed from swine before slaughter on carcass and viscera weights and meat quality.
• Endocrinology: the active partner in PNI research.
• Energy transduction: proton transfer through the respiratory complexes.
• Evaluation of online and on-site options for master's degree and post-master's certificate programs.
• Foundation year two in ENT: a brave new (training) world.
• Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
• Location, allocation, relocation: isolating adult tissue stem cells in three dimensions.
• Neuromuscular disease of the urinary tract in infants and children.
• Occupational differences in job strain and physiological stress: female nurses and school teachers in Hawaii.
• Peptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus 229E exhibit high affinity binding to the formyl peptide receptor.
• Polybrominated diphenyl ethers in the sediments of the Great Lakes. 4. Influencing factors, trends, and implications.
• Preliminary assessment of remote photoelectric excitation of an actuator for a hearing implant.
• Ratings of perceived inspiratory breathing effort during a 30-repetition maximum inspiratory muscle training session: 621: may 30 4:45 PM 5:00 PM.
• Sin Nombre virus infection of deer mice in Montana: characteristics of newly infected mice, incidence, and temporal pattern of infection.
• The Benefits Of Sandwalking For Improving Strength And Physical Fitness In Elderly Women: 2299: Board #212 June 1 9:00 AM -10:30 AM.
• The maturation of mucus-secreting gastric epithelial progenitors into digestive-enzyme secreting zymogenic cells requires Mist1.
• The potential anti-inflammatory benefits of improving physical fitness in hypertension.
• X-ray Optics Developments at the APS for the Third Generation of High-Energy Synchrotron Radiation Sources.